[Proxybarbital (Ipronal) in the pathogenetic treatment of irritable bowel syndrome].
D000328:Adult; D001463:Barbiturates / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003109:Colonic Diseases, Functional / Q000188:drug therapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D010919:Placebos
D001463:Barbiturates; D010919:Placebos
Proksybarbital (Ipronal) w przyczynowym leczeniu zespołu jelita nadpobudliwego.